Abstract:Background The head-twitch response (HTR) in mice is considered a behavioral model for hallucinogens and serotonin 5-HT 2A receptor function, as well as Tourette syndrome in humans. It is mediated by 5-HT 2A receptor agonists such as ( ±)− 2,5-dimethoxy-4-iodoamphetamine (DOI) in the prefrontal cortex (PFC). The 5-HT 2A antagonist EMD 281014, can prevent both DOI-induced HTR during ageing and c-fos expression in different regions of PFC. Moreover, the nonselective monoamine releaser methamphetamine (MA) suppressed DOI-induced HTR through ageing via concomitant activation of inhibitory 5-HT 1A receptors, but enhanced DOI-evoked c-fos expression. d -Fenfluramine is a selective 5-HT releaser and induces HTR in mice, whereas MA does not. Currently, we investigated whether EMD 281014 or MA would alter: (1) d -fenfluramine-induced HTR frequency in 20-, 30- and 60-day old mice, (2) d -fenfluramine-evoked c- fos expression in PFC, and (3) whether blockade of inhibitory serotonergic 5-HT 1A - or adrenergic ɑ 2 -receptors would prevent suppressive effect of MA on d -fenfluramine-induced HTR. Results EMD 281014 (0.001–0.05 mg/kg) or MA (0.1–5 mg/kg) blocked d -fenfluramine-induced HTR dose-dependently during ageing. The 5-HT 1A antagonist WAY 100635 countered the inhibitory effect of MA on d -fenfluramine-induced HTR in 30-day old mice, whereas the adrenergic ɑ 2 antagonist RS 79948 reversed MA’s inhibitory effect in both 20- and 30- day old mice. d -Fenfluramine significantly increased c- fos expressions in PFC regions. MA (1 mg/kg) pretreatment significantly increased d -fenfluramine-evoked c- fos expression in different regions of PFC. EMD 281014 (0.05 mg/kg) failed to prevent d -fenfluramine-induced c- fos expression, but significantly increased it in one PFC region (PrL at − 2.68 mm). Conclusion EMD 281014 suppressed d -fenfluramine-induced HTR but failed to prevent d -fenfluramine-evoked c- fos expression which suggest involvement of additional serotonergic receptors in the mediation of evoked c- fos . The suppressive effect of MA on d -fenfluramine-evoked HTR is due to well-recognized functional interactions between stimulatory 5-HT 2A - and the inhibitory 5-HT 1A - and ɑ 2 -receptors. MA-evoked increases in c- fos expression in PFC regions are due to the activation of diverse monoaminergic receptors through increased synaptic concentrations of 5-HT, NE and/or DA, which may also account for the additive effect of MA on d -fenfluramine-evoked changes in c- fos expression. Our findings suggest potential drug receptor functional interaction during development when used in combination.

Exposure to Far Infrared Ray Protects Methamphetamine-Induced Behavioral Sensitization in Glutathione Peroxidase-1 Knockout Mice via Attenuating Mitochondrial Burdens and Dopamine D1 Receptor Activation

Exposure to far-infrared ray attenuates methamphetamine-induced impairment in recognition memory through inhibition of protein kinase C δ in male mice: Comparison with the antipsychotic clozapine

N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users

Metabolites Alterations in the Medial Prefrontal Cortex of Methamphetamine Users in Abstinence: A 1H MRS Study

Psilocin Suppresses Methamphetamine‐induced Hyperlocomotion and Acquisition of Conditioned Place Preference Via D2R‐mediated ERK Signaling

Fluoxetine protects against methamphetamine-induced lung inflammation by suppressing oxidative stress through the SERT/p38 MAPK/Nrf2 pathway in rats

Fas and GIT1 signalling in the prefrontal cortex mediate behavioural sensitization to methamphetamine in mice

Selective Activation of Striatal NGF-TrkA/p75NTR/MAPK Intracellular Signaling in Rats That Show Suppression of Methamphetamine Intake 30 Days following Drug Abstinence

Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice

Effects of Low-Doses of Methamphetamine on D-Fenfluramine-induced Head-Twitch Response (HTR) in Mice During Ageing and C-Fos Expression in the Prefrontal Cortex

p-Nrf2/HO-1 Pathway Involved in Methamphetamine-induced Executive Dysfunction through Endoplasmic Reticulum Stress and Apoptosis in the Dorsal Striatum

Role of Dopamine D3 Receptors in Methamphetamine-Induced Behavioural Sensitization and the Characterization of Dopamine Receptors (D1R–D5R) Gene Expression in the Brain

Knockout of Dopamine D3 Receptor Gene Blocked Methamphetamine-Induced Distinct Changes of Dopaminergic and Glutamatergic Synapse in the Nucleus Accumbens Shell of Mice

Tetrahydropalmatine Protects Against Methamphetamine-Induced Spatial Learning and Memory Impairment in Mice

Ifenprodil attenuates the acquisition and expression of methamphetamine-induced behavioral sensitization and activation of Ras-ERK1/2 cascade in the caudate putamen.

Quercetin Mitigates Methamphetamine-Induced Anxiety-Like Behavior Through Ameliorating Mitochondrial Dysfunction and Neuroinflammation.

Ifenprodil Attenuates Methamphetamine-Induced Behavioral Sensitization and Activation of Ras-ERK-∆FosB Pathway in the Caudate Putamen

An Ontogenic Study of Receptor Mechanisms by Which Acute Administration of Low-Doses of Methamphetamine Suppresses DOI-induced 5-Ht2a-receptor Mediated Head-Twitch Response in Mice

Short-chain fatty acids mitigate Methamphetamine-induced hepatic injuries in a Sigma-1 receptor-dependent manner

Behavioral Sensitization Induced by Methamphetamine Causes Differential Alterations in Gene Expression and Histone Acetylation of the Prefrontal Cortex in Rats

Involvement of Dopamine D2 Receptor in a Single Methamphetamine-Induced Behavioral Sensitization in C57BL/6J Mice